why choose us

First received: June 26, 2023

Clinical Trial: Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Traumatic Brain Injury

Study Type: INTERVENTIONAL


Official Title: Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Brief Summary: The global objective of this study is to establish the safety and investigate the potential treatment effect of an intravenous infusion of HB-adMSCs (Hope Biosciences adipose-derived mesenchymal stem cells) on brain structure, neurocognitive/functional outcomes, and neuroinflammation after traumatic brain injury and/or hypoxic-ischemic encephalopathy in adults.

Read more